BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2049779)

  • 1. Investigation on phosphate dependent glutaminase (EC 3.5.1.2) activity in host tissues of EAC-bearing mice and response of liver EC 3.5.1.2 on Cu-ATP therapy.
    Pal S; Nayak KK; Maity P
    Cancer Lett; 1991 Jun; 58(1-2):151-3. PubMed ID: 2049779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on glutamine amidohydrolase (EC 3.5.1.2) and glutamine aminotransferase (EC 2.5.1.15) activity in liver and plasma of EAC-bearing mice following glutaminase therapy.
    Pal S; Maity P
    Cancer Lett; 1992 Oct; 66(3):225-31. PubMed ID: 1451103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficacy of glutaminase-copper-ATP combination in mice bearing Ehrlich ascites carcinoma.
    Pal S; Maity P
    Anticancer Drugs; 1994 Feb; 5(1):57-63. PubMed ID: 8186431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in ornithine decarboxylase activity in normal tissues of tumor-bearing mice during tumor growth.
    Noguchi T; Kashiwagi A; Tanaka T
    J Biochem; 1976 Feb; 79(2):451-4. PubMed ID: 1270412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system.
    Segura JA; Ruiz-Bellido MA; Arenas M; Lobo C; Márquez J; Alonso FJ
    Int J Cancer; 2001 Feb; 91(3):379-84. PubMed ID: 11169963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
    Maity P; Chakraborty S; Bhattacharya P
    J Exp Clin Cancer Res; 2000 Jun; 19(2):161-4. PubMed ID: 10965812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early differential expression of two glutaminase mRNAs in mouse spleen after tumor implantation.
    Aledo JC; Segura JA; Barbero LG; Márquez J
    Cancer Lett; 1998 Nov; 133(1):95-9. PubMed ID: 9929166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of glutamine aminohydrolases in subcellular fractions of liver of tumour bearing mice.
    Chaudhury S; Chaudhury L; Shrivastava GC
    Experientia; 1975 Dec; 31(12):1459-61. PubMed ID: 2490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in mRNAs for enzymes of glutamine metabolism in the tumor-bearing mouse.
    Aledo JC; de Pedro E; Gómez-Fabre PM; Núñez de Castro IN; Márquez J
    Anticancer Res; 2000; 20(3A):1463-6. PubMed ID: 10928057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution by host tissues to circulating glutamine in mice inoculated with Ehrlich ascites tumor cells.
    Quesada AR; Medina MA; Márquez J; Sánchez-Jiménez FM; Núñez de Castro I
    Cancer Res; 1988 Mar; 48(6):1551-3. PubMed ID: 2894241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate-activated glutaminase expression during tumor development.
    Aledo JC; Segura JA; Medina MA; Alonso FJ; Núñez de Castro I; Márquez J
    FEBS Lett; 1994 Mar; 341(1):39-42. PubMed ID: 8137919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitisation of Ehrlich ascitic tumour cells to methotrexate by inhibiting glutaminase.
    Alonso FJ; Segura JA; Lora J; Lobo C; Fernández-Molina B; Márquez J; Matés JM
    Anticancer Res; 2005; 25(5):3315-20. PubMed ID: 16101144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A factor responsible for increases in ornithine decarboxylase activity in the livers of tumor-bearing mice.
    Noguchi T; Kashiwagi A; Tanaka T
    Cancer Res; 1976 Nov; 36(11 Pt 1):4015-22. PubMed ID: 975047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submitochondrial localization and membrane topography of Ehrlich ascitic tumour cell glutaminase.
    Aledo JC; de Pedro E; Gómez-Fabre PM; Núñez de Castro I; Márquez J
    Biochim Biophys Acta; 1997 Jan; 1323(2):173-84. PubMed ID: 9042341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminase activities in normal and neoplastic tissues of the rat.
    Knox WE; Tremblay GC; Spanier BB; Friedell GH
    Cancer Res; 1967 Aug; 27(8):1456-8. PubMed ID: 6047874
    [No Abstract]   [Full Text] [Related]  

  • 16. L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.
    Kikuchi H; Kobayashi Y; Tsuiki S
    Biochim Biophys Acta; 1971 Jun; 237(3):412-21. PubMed ID: 4330266
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of glycolysis and mitochondrial respiration of Ehrlich ascites carcinoma cells by methylglyoxal.
    Halder J; Ray M; Ray S
    Int J Cancer; 1993 May; 54(3):443-9. PubMed ID: 8509219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase isoenzymes in tissues of normal and Ehrlich-Lettré ascites tumor-bearing Swiss mice.
    Fountain JA; Parks ME; Dickey A; McKee RW
    Cancer Res; 1970 Apr; 30(4):998-1002. PubMed ID: 4251323
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.
    Lobo C; Ruiz-Bellido MA; Aledo JC; Márquez J; Núñez De Castro I; Alonso FJ
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):257-61. PubMed ID: 10816417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native polyacrylamide gel electrophoresis of membrane proteins: glutaminase detection after in situ specific activity staining.
    Aledo JC; Gómez-Biedma S; Segura JA; Molina M; Núñez de Castro I; Márquez J
    Electrophoresis; 1993; 14(1-2):88-93. PubMed ID: 7681775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.